Event-Driven Stocks

ARMO BioSciences, Inc.

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

Financials

SEC XBRL · annual

No structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).

Insider transactions

SEC Form 4 · most recent
0 acquisitions7 disposalsnet 18.4M shares · last 7
InsiderDateTypeSharesPrice
Xu StellaDirectorJun 22, 2018U404,900$50.00
Van Vlasselaer PeterOfficer — President and CEOJun 22, 2018U809,865$50.00
Orbimed Advisors LlcDirectorJun 22, 2018U3.7M$50.00
Kleiner Perkins Caufield &Amp; Byers Xiv, Llc10% ownerJun 22, 2018U4.3M$50.00
Cui XiangminDirectorJun 22, 2018U1.2M$50.00
Seidenberg Beth CDirectorJun 22, 2018U4.3M$50.00
Gordon Carl LDirectorJun 22, 2018U3.7M$50.00

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.